Total Funding
58
72
Total FundingGrant raised
Growth Score 58 in past quarter
-26 pts
Heat Score 72 in past quarter
-1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
44365
Noul is a research company that conducts biotechnology research on blood testing platforms for medical facilities and clinics.
- Peter Kim: Co-Founder, Attorney and CLO
- Steve Lee: Co-Founder and CSO
About the Company
Noul offers solutions for chronic and systemic problems in healthcare. Noul adapts invitro diagnostics to improve medical access with innovative diagnostic solutions. It focuses on enhancing human health by contributing to the eradication of infectious and non-infectious diseases that are considered as some of the threats to global health.